Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain

Mechanisms of Ageing and Development

Volumn 132, Issue 8-9, 2011, Pages 443-448

  Lovell, Mark A ^a,b   Soman, Sony ^a   Bradley, Melissa A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Base excision repair; DNA oxidation; Oxidative stress; Preclinical AD; RNA oxidation

Indexed keywords

8 HYDROXYGUANINE; 8 OXOGUANINE GLYCOSYLASE; MESSENGER RNA; MITOCHONDRIAL RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA OXIDATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE TEMPORAL GYRUS; NERVE CELL; OXIDATION; PARAHIPPOCAMPAL GYRUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA OXIDATION; SUPERIOR TEMPORAL GYRUS;

ALZHEIMER DISEASE; AUTOPSY; BRAIN; DNA; DNA DAMAGE; DNA GLYCOSYLASES; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANINE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; RNA, MESSENGER;

EID: 80053110019     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2011.08.003     Document Type: Article

References (37)

1. Aluise C.D., Robinson R.A., Beckett T.L., Murphy M.P., Cai J., Pierce W.M., Markesbery W.R., Butterfield D.A. Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiol. Dis. 2010, 39:221-228.
2. Beelman C.A., Parker R. Degradation of mRNA in eukaryotes. Cell 1995, 81:179-183.
3. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radic. Biol. Med. 2010, 48:1570-1576.
4. Bradley M.A., Xiong-Fister S., Markesbery W.R., Lovell M.A. Elevated 4-hydroxyhexenal in Alzheimer's disease (AD) progression. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.08.016.
5. Ding Q., Markesbery W.R., Cecarini V., Keller J.N. Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem. Res. 2006, 31:705-710.
6. Ding Q., Markesbery W.R., Chen Q., Li F., Keller J.N. Ribosome dysfunction is an early event in Alzheimer's disease. J. Neurosci. 2005, 25:9171-9175.
7. Jezowska-Bojczuk M., Szczepanik W., Lesniak W., Ciesiolka J., Wrzesinski J., Bal W. DNA and RNA damage by Cu(II)-amikacin complex. Eur. J. Biochem. 2002, 269:5547-5556.
8. Lovell M.A., Markesbery W.R. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer's disease. Nucleic Acids Res. 2007, 35:7497-7504.
9. Lovell M.A., Markesbery W.R. Oxidatively modified RNA in mild cognitive impairment. Neurobiol. Dis. 2008, 29:169-175.
10. Lovell M.A., Xie C., Makresbery W.R. Decreased base excision repair and increased helicase activity in Alzheimer's disease brain. Brain Res. 2000, 855:166-173.
11. Lovell M.A., Xie C., Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol. Aging 2001, 22:187-194.
12. Mao G., Pan X., Zhu B.B., Zhang Y., Yuan F., Huang J., Lovell M.A., Lee M.P., Markesbery W.R., Li G.M., Gu L. Identification and characterization of OGG1 mutations in patients with Alzheimer's disease. Nucleic Acids Res. 2007, 35:2759-2766.
13. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 1998, 19:33-36.
14. Markesbery W.R., Kryscio R.J., Lovell M.A., Morrow J.D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol. 2005, 58:730-735.
15. Martinet W., de Meyer G.R., Herman A.G., Kockx M.M. Reactive oxygen species induce RNA damage in human atherosclerosis. Eur. J. Clin. Invest. 2004, 34:323-327.
16. McGarth L.T., McGleenon B.M., Brennan S., McColl D., McIlroy S., Passmore A.P. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. Q. J. Med. 2001, 94:385-490.
17. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Am. Neurol. Assoc. 1994, 36:747-751.
18. Mitchell P., Tollervey D. mRNA turnover. Curr. Opin. Cell Biol. 2001, 13:320-325.
19. Nunomura A., Perry G., Hirai K., Aliev G., Takeda A., Chiba S., Smith M.A. Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann. NY Acad. Sci. 1999, 893:362-364.
20. Nunomura A., Chiba S., Kosaka K., Takeda A., Castellani R.J., Smith M.A., Perry G. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies. Neuroreport 2002, 13:2035-2039.
21. Nunomura A., Chiba S., Lippa C.F., Cras P., Kalaria R.N., Takeda A., Honda K., Smith M.A., Perry G. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol. Dis. 2004, 17:108-113.
22. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:759-767.
23. Reich E.E., Markesbery W.R., Roberts L.J., Swifte L.L., Morrow J.D., Montine T.J. Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am. J. Pathol. 2001, 158:293-297.
24. Rinke J., Brimacombe R. 30S ribosomal proteins cross-linked to 16S RNA by periodate oxidation followed by borohydride reduction. Mol. Biol. Rep. 1978, 4:153-156.
25. Shan X., Lin C.L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging 2006, 27:657-662.
26. Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 2003, 23:4913-4921.
27. Shao C., Xiong S., Li G.M., Gu L., Mao G., Markesbery W.R., Lovell M.A. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain. Free Radic. Biol. Med. 2008, 45:813-819.
28. Singh S., Dwarakanath B.S., Mathew T.L. DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines. J. Photochem. Photobiol. B 2004, 77:45-54.
29. Sultana R., Butterfield D.A. Role of oxidative stress in the progression of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:341-353.
30. Sultana R., Perluigi M., Butterfield D.A. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 2006, 8:2021-2037.
31. Tucker M., Parker R. Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu. Rev. Biochem 2000, 69:571-595.
32. van Hoof A., Parker R. The exosome: a proteasome for RNA?. Cell 1999, 3:7-350.
33. van Hoof A., Parker R. Messenger RNA degradation: beginning at the end. Curr. Biol. 2002, 12:R285-R287.
34. Wang J., Markesbery W.R., Lovell M.A. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J. Neurochem. 2006, 96:825-832.
35. Weissman L., Jo D.G., Sorensen M.M., de Souza-Pinto N.C., Markesbery W.R., Mattson M.P., Bohr V.A. Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment. Nucleic Acids Res. 2007, 35:5545-5555.
36. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neurobiol. Aging 2006, 27:1094-1099.
37. Zhang J., Perry G., Smith M.A., Robertson D., Olson S.J., Graham D.G., Montine T.J. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am. J. Pathol. 1999, 154:1423-1429.